HRTX: Prakiraan rega marang bathi Heron Therapeutics Inc

Tandha merek Heron Therapeutics (HRTX)

This daily price chart for Heron Therapeutics (HRTX) reflects the 0.00 metric, while the business focuses on developing treatments for chemotherapy side effects and managing acute pain without the use of opioids. The organization is effectively recruiting compliance and sales experts, maintaining a personnel balance following a reduction in R&D expenditures.

Rasio prakiraan rega marang bathi: herontx.com (HRTX) kanggo 04.07.2022 - 17.11.2026

Rincian metrik lan analitis perusahaan herontx.com (HRTX)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:HRTX Heron Therapeutics Inc
Produk merek Heron Therapeutics

An investor assesses an asset's prospects through the balance of current value and expected returns. The forward P/E ratio compares the market price of a share with the estimated earnings for the future period, revealing the extent of overvaluation. For Heron Therapeutics (HRTX), this calculation confirms the sales efficiency of its anesthesia and oncology drugs. Stable hospital demand ensures a steady cash flow. By analyzing the company's forward P/E value, one can determine whether the market quotes are justified.